BOOSTRIX
- Product NDC
- 50090-1377
- 11-digit product format
- 500901377
- Labeler code
- 50090
- Product ID
- 50090-1377_2e2b4c6a-d397-41b8-babf-adc104e8fbef
- Type
- VACCINE
- Nonproprietary name
- Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed
- Dosage form
- SUSPENSION
- Route
- INTRAMUSCULAR
- Labeler
- A-S Medication Solutions
- Application
- BLA125106
- Marketing category
- BLA
- Marketing start
- 2009-07-24
- Substance
- BORDETELLA PERTUSSIS FILAMENTOUS HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED); BORDETELLA PERTUSSIS PERTACTIN ANTIGEN (FORMALDEHYDE INACTIVATED); BORDETELLA PERTUSSIS TOXOID ANTIGEN (FORMALDEHYDE, GLUTARALDEHYDE INACTIVATED); CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED); CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED)
- Active strength
- 8; 2.5; 8; 5; 2.5 ug/.5mL; ug/.5mL; ug/.5mL; [iU]/.5mL; [iU]/.5mL
- Pharmacologic classes
- Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Diphtheria Toxoid [CS], Inactivated Bordetella Pertussis Vaccine [EPC], Inactivated Bordetella Pertussis Vaccine [EPC], Inactivated Bordetella Pertussis Vaccine [EPC], Inactivated Clostridium Tetani Vaccine [EPC], Inactivated Corynebacterium Diphtheriae Vaccine [EPC], Pertussis Vaccine [CS], Pertussis Vaccine [CS], Pertussis Vaccine [CS], Tetanus Toxoid [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS], Vaccines, Inactivated [CS]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- BOOSTRIX
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| BORDETELLA PERTUSSIS FILAMENTOUS HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED) | 8 ug/.5mL |
| BORDETELLA PERTUSSIS PERTACTIN ANTIGEN (FORMALDEHYDE INACTIVATED) | 2.5 ug/.5mL |
| BORDETELLA PERTUSSIS TOXOID ANTIGEN (FORMALDEHYDE, GLUTARALDEHYDE INACTIVATED) | 8 ug/.5mL |
| CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED) | 5 [iU]/.5mL |
| CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED) | 2.5 [iU]/.5mL |
FDA-Initiated Inactive NDC Indexing#
NDC, Effective, Action table| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|
| 50090-1377-0 | 2023-06-22 | C162847 | 48780-1 | f386c64a-2198-0266-e053-dadaa90a7c1a | These highlights do not include all the information needed to use BOOSTRIX safely and effectively. See full prescribing information for BOOSTRIX. BOOSTRIX (Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed) injectable suspension, for intramuscular use Initial U.S. Approval: 2005 |
| 50090-1377-1 | 2023-06-22 | C162847 | 48780-1 | f386c64a-2198-0266-e053-dadaa90a7c1a | These highlights do not include all the information needed to use BOOSTRIX safely and effectively. See full prescribing information for BOOSTRIX. BOOSTRIX (Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed) injectable suspension, for intramuscular use Initial U.S. Approval: 2005 |
| 50090-1377-0 | 2023-01-30 | C162847 | 48780-1 | f386c64a-2198-0266-e053-dadaa90a7c1a | These highlights do not include all the information needed to use BOOSTRIX safely and effectively. See full prescribing information for BOOSTRIX. BOOSTRIX (Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed) injectable suspension, for intramuscular use Initial U.S. Approval: 2005 |
| 50090-1377-1 | 2023-01-30 | C162847 | 48780-1 | f386c64a-2198-0266-e053-dadaa90a7c1a | These highlights do not include all the information needed to use BOOSTRIX safely and effectively. See full prescribing information for BOOSTRIX. BOOSTRIX (Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed) injectable suspension, for intramuscular use Initial U.S. Approval: 2005 |
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 50090-1377-0 | BOOSTRIX | 10 in 1 CARTON | SUSPENSION | 10 | | 26 |
| 50090-1377-1 | BOOSTRIX | .5 mL in 1 SYRINGE | SUSPENSION | .5 | | 26 |
| 50090-1377-1 | BOOSTRIX | 1 in 1 POUCH | SUSPENSION | 1 | | 26 |
| 50090-1377-2 | BOOSTRIX | .5 mL in 1 SYRINGE | SUSPENSION | .5 | | 26 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 50090-1377 | BOOSTRIX (TETANUS TOXOID, REDUCED DIPHTHERIA TOXOID AND ACELLULAR PERTUSSIS VACCINE, ADSORBED) SUSPENSION [A-S MEDICATION SOLUTIONS] | 26 | Current NDC, Legacy NDC, 4 package rows | 20250508_c3c03458-942c-4565-8a9c-1901bb0d2db0.zip |
DailyMed RxNorm Mappings#
RxCUI, RxNorm string, TTY table| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|
| 1300370 | BOOSTRIX vaccine 0.5 ML Prefilled Syringe | PSN | c3c03458-942c-4565-8a9c-1901bb0d2db0 | 26 |
| 1300368 | Tdap (generic for Boostrix) 0.5 ML Prefilled Syringe | PSN | c3c03458-942c-4565-8a9c-1901bb0d2db0 | 26 |
| 1300370 | 0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.016 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.005 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.016 MG/ML / diphtheria toxoid vaccine, inactivated 5 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Prefilled Syringe [Boostrix] | SBD | c3c03458-942c-4565-8a9c-1901bb0d2db0 | 26 |
| 1300368 | 0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.016 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.005 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.016 MG/ML / diphtheria toxoid vaccine, inactivated 5 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Prefilled Syringe | SCD | c3c03458-942c-4565-8a9c-1901bb0d2db0 | 26 |
| 1300370 | Boostrix (Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 8 MCG / Bordetella pertussis pertactin vaccine, inactivated 2.5 MCG / Bordetella pertussis toxoid vaccine, inactivated 8 MCG / diphtheria toxoid vaccine, inactivated 2.5 UNT / tetanus toxoid vaccine, inactivated 5 UNT) per 0.5 ML Prefilled Syringe | SY | c3c03458-942c-4565-8a9c-1901bb0d2db0 | 26 |
| 1300370 | Boostrix Tdap (Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed) 0.5 ML Prefilled Syringe | SY | c3c03458-942c-4565-8a9c-1901bb0d2db0 | 26 |
| 1300368 | Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 8 MCG / Bordetella pertussis pertactin vaccine, inactivated 2.5 MCG / Bordetella pertussis toxoid vaccine, inactivated 8 MCG / diphtheria toxoid vaccine, inactivated 2.5 UNT / tetanus toxoid vaccine, inactivated 5 UNT per 0.5 ML Prefilled Syringe | SY | c3c03458-942c-4565-8a9c-1901bb0d2db0 | 26 |
| 1300368 | Tdap (tetanus toxoid vaccine, inactivated 5 UNT / diphtheria toxoid vaccine, inactivated 2.5 UNT / acellular pertussis vaccine, inactivated 18.5 MCG) per 0.5 ML Prefilled Syringe | SY | c3c03458-942c-4565-8a9c-1901bb0d2db0 | 26 |
| 1300368 | tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine, adsorbed (Tdap generic for Boostrix) 0.5 ML Prefilled Syringe | SY | c3c03458-942c-4565-8a9c-1901bb0d2db0 | 26 |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 50090-1377-0 | 50090137700 | 10 SYRINGE in 1 CARTON (50090-1377-0) / .5 mL in 1 SYRINGE (50090-1377-2) | 10 syringe | 2009-07-24 | 0000-00-00 | No | No | Current |
| 50090-1377-1 | 50090137701 | 1 SYRINGE in 1 POUCH (50090-1377-1) / .5 mL in 1 SYRINGE | 1 syringe | 2009-07-24 | 0000-00-00 | No | No | Current |
| 50090-1377-2 | 50090137702 | .5 mL in 1 SYRINGE | | | | | | Historical |